Chronic Disease — Entidade

benefitscanada.com·há cerca de 1 mês

Canadian employers expanding GLP-1 coverage for weight loss: survey

Nearly two-fifths (37 per cent) of Canadian employers cover glucagon-like peptide-1 therapies for both diabetes and weight loss, up from 31 per cent in 2025 and just 17 per cent in 2024, according to

publichealth.uci.edu·há 3 meses

‘Dad bods’ may influence childhood obesity risks

Originally posted on UC Irvine News. As obesity rates rise across the U.S., new research from Joe C. Wen School of Population & Public Health at the University of California, Irvine scientists draws

benefitscanada.com·há 3 meses

Coverage of the 2026 Vancouver Benefits Summit

On April 9 at the Marriott Pinnacle Downtown in Vancouver, the 2026 Vancouver Benefits Summit hosted a record-breaking crowd of B.C.-based employers, advisors and consultants for a full day of educati

benefitscanada.com·há 3 meses

Report finds financial stress shaping health claims across all employee age groups

Employers are facing growing pressure on their benefits plans as financial stress shapes how employees access care, use coverage and experience health outcomes across life stages, according to a new r

benefitscanada.com·há 4 meses

2026 Women’s Health & Wealth Summit: A look at the emerging trends in the gender health gap

A long history of inadequate recognition and support for women’s health has rifted the gender health gap. Indeed, a variety of health issues affect women differently, disproportionately and exclusivel

publichealth.uci.edu·há 4 meses

Study finds young adult cancer survivors experience symptoms years after treatment

A new study from Project Milestones, an National Cancer Institute-funded (R01) initiative led by Joel Milam, PhD, professor of epidemiology & biostatistics at the UC Irvine Joe C. Wen School of Popula

benefitscanada.com·há 4 meses

Weight management drugs, rare disease treatments expected to drive private drug plan costs in 2026: report

Weight management drugs and high-cost specialty treatments are expected to have the biggest impact on private drug plans this year, according to Telus Health’s annual drug pipeline report. It fo

benefitscanada.com·há 5 meses

Coverage of the 2026 Chronic Disease at Work conference

For the past 11 years, Benefits Canada’s Chronic Disease at Work conference has examined the current trends in chronic disease in Canada and what they mean for plan sponsors. In a virtual format on Fe